Hernandez Reyes, J.d.l.C.; Santos Morales, O.; Hernandez Moreno, L.; Pino Alfonso, P.P.; Neninger Vinageras, E.; Knigths Montalvo, J.L.; Aguilar Sosa, A.; Gonzalez Morera, A.; Lorenzo-Luaces Alvárez, P.; Aguilar Venegas, Y.;
et al. PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients. Vaccines 2024, 12, 833.
https://doi.org/10.3390/vaccines12080833
AMA Style
Hernandez Reyes JdlC, Santos Morales O, Hernandez Moreno L, Pino Alfonso PP, Neninger Vinageras E, Knigths Montalvo JL, Aguilar Sosa A, Gonzalez Morera A, Lorenzo-Luaces Alvárez P, Aguilar Venegas Y,
et al. PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients. Vaccines. 2024; 12(8):833.
https://doi.org/10.3390/vaccines12080833
Chicago/Turabian Style
Hernandez Reyes, Jenysbel de la C., Orestes Santos Morales, Laura Hernandez Moreno, Pedro Pablo Pino Alfonso, Elia Neninger Vinageras, Julia Lilliam Knigths Montalvo, Aliuska Aguilar Sosa, Amnely Gonzalez Morera, Patricia Lorenzo-Luaces Alvárez, Yadira Aguilar Venegas,
and et al. 2024. "PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients" Vaccines 12, no. 8: 833.
https://doi.org/10.3390/vaccines12080833
APA Style
Hernandez Reyes, J. d. l. C., Santos Morales, O., Hernandez Moreno, L., Pino Alfonso, P. P., Neninger Vinageras, E., Knigths Montalvo, J. L., Aguilar Sosa, A., Gonzalez Morera, A., Lorenzo-Luaces Alvárez, P., Aguilar Venegas, Y., Troche Concepción, M., Medel Pérez, L., Santiesteban González, Y., GarcÃa Fernández, L., Regueiro RodrÃguez, L., MacÃas Abrahan, A., Labrada Mon, M., León Monzón, K., Saavedra Hernández, D.,
& Crombet Ramos, T.
(2024). PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients. Vaccines, 12(8), 833.
https://doi.org/10.3390/vaccines12080833
